MCX shares recover after early fall, Morgan Stanley and UBS issue contrasting notes

Morgan Stanley remains cautious with an 'Underweight' rating on MCX, while UBS has maintained a 'Buy' stance but revised its price target lower. Investors are awaiting clarity on regulatory approval for MCX's weekly options, which could offer upside potential for the exchange..